Lasmiditan for single migraine attack in Japanese patients with cardiovascular risk factors: subgroup analysis of a phase 2 randomized placebo-controlled trial
Sign Up to like & getrecommendations! Published in 2022 at "Expert Opinion on Drug Safety"
DOI: 10.1080/14740338.2022.2078302
Abstract: ABSTRACT Background Some migraine treatments are contraindicated for patients with cardiovascular disease (CVD) or risk factors (CVRFs). We report safety and efficacy of lasmiditan, a new oral acute migraine treatment with no cardiovascular contraindication, in… read more here.
Keywords: patients cardiovascular; migraine; japanese patients; cvrf ... See more keywords
Consequences of diabetes and high-risk dyslipidemia
Sign Up to like & getrecommendations! Published in 2023 at "European Journal of Preventive Cardiology"
DOI: 10.1093/eurjpc/zwad125.161
Abstract: Type of funding sources: None. Diabetic patients develop both, microvascular and macrovascular long-term complications, and have double the risk of cardiovascular (CV) disease being the main cause of death. The 97% of diabetic patients are… read more here.
Keywords: disease; cvrf; high risk; risk ... See more keywords
Circulating miR-29b decrease in response to sarcopenia in patients with cardiovascular risk factors in older Chinese
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Cardiovascular Medicine"
DOI: 10.3389/fcvm.2022.1094388
Abstract: Introduction Sarcopenia is a clinical syndrome characterized by a progressive and extensive decline in skeletal muscle mass, muscle strength, and function. Sarcopenia and cardiovascular diseases (CVDs) can coexist, which further decreases the quality of life… read more here.
Keywords: mir 29b; cvrf; risk; sarcopenia ... See more keywords